Orchid Island Capital ORC 深 沪
已收盘 09-19 16:00:00 美东时间
7.00
-0.080
-1.13%
华盛通- 最 高7.135
- 今 开7.11
- 成交量 1179.61万股
- 最 低 6.95
- 昨 收 7.08
- 总市值 10.22亿
- 52周最高 8.165
- 市盈率 静 12.17
- 换手率 8.08%
- 52周最低 5.085
- 委 比 -22.59%
- 总股本 1.46亿
- 历史最高 30.625
- 量 比 3.64
- 振 幅 2.61%
- 历史最低 -8.61
- 每 手 1
- 风险率 0.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美国多名民主党参议员首提决议案 呼吁承认巴勒斯坦国
据新华社消息，美国多名民主党籍国会参议员18日提出参议院首份呼吁承认巴勒斯坦国的决议案。最新民调显示，越来越多美国人认为以色列在加沙地带的军事行动“过度”。就在...
09-19 15:25
国金机械丨磁悬浮制冷压缩机：制冷系统核心设备，AIDC催化景气度上行
（来源：满仓机械） 投资逻辑 AIDC机柜算力密度升级，推升高性能散热需求。AIDC算力的密度较高，当前单机柜功耗已从2-8...
09-16 22:18
The 4 Conflicting Ways I'm Thinking About The Economy
Last year, I wrote about how there arefour different ways your view of th...
09-09 21:05
芯碁微装冲击A+H，专注于光刻设备领域，应收账款压力较大
创业板指昨日跌超4%，今天就实现“反包”，为近十年来首次! PCB龙头胜宏科技（300476.SZ）再次20cm涨停，年内涨幅已超6倍。 与此同时，胜宏科技的光...
09-05 17:48
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
Orchestra BioMed announced that AVIM therapy, a new treatment for uncontrolled hypertension, demonstrated sustained blood pressure reduction, reversibility, and reproducibility in long-term follow-up. Key findings include a 3.6-year follow-up showing a 8.9 mmHg reduction in systolic blood pressure, no rebound hypertension upon deactivation, and immediate restoration of effects upon reactivation. The therapy has FDA Breakthrough Device Designation...
09-04 21:00
Clean Energy Technologies Announces Successful Completion And Delivery Of Its Heat Recovery Systems Under The Previously Announced Agreement With Sagacity
Clean Energy Technologies, Inc. (NASDAQ:CETY) ("CETY" or the "Company"), a clean energy technology company delivering scalable solutions in power generation, storage, waste-to-energy, and heat-to-power, today announced
09-04 20:49
Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years
HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a large smoking cessation market.
08-22 02:11
Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction
AvIM Therapy Shows Promise in Treating Hypertension and Diastolic Dysfunction. MODERATO II study demonstrates significant reductions in systolic blood pressure and improvements in cardiac function in patients with hypertension and diastolic dysfunction, a key contributor to heart failure with preserved ejection fraction (HFpEF). The study highlights the potential of AVIM therapy to address unmet medical needs in managing hypertensive heart diseas...
08-14 12:00
Orchid Island Capital declares $0.12 dividend
Orchid Island Capital (NYSE:ORC) declares $0.12/share monthly dividend, in line with previous. Forward yield 20.11% Payable Sept. 29; for shareholders of record Aug. 29; ex-div Aug. 29. See ORC Divide...
08-14 05:26
